Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.04
0.021.96%
Last update: Apr 22, 1:15 PM
Heron Therapeutics Inc (HRTX) Stock Price, Quote, News & History
HRTXNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Heron Therapeutics (HRTX) stock?
You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.
Who are Heron Therapeutics (HRTX) competitors?
Other companies in Heron Therapeutics’s space includes: Molecular Partners AG (NASDAQ:MOLN), Atrium Therapeutics Inc (NASDAQ:RNA), ProQR Therapeutics NV (NASDAQ:PRQR), Korro Bio Inc (NASDAQ:KRRO) and Burning Rock Biotech Ltd (NASDAQ:BNR).
What is the forecast, or price target, for Heron Therapeutics (HRTX) stock?
Heron Therapeutics has a consensus price target of $5.50.
What is the current price for Heron Therapeutics (HRTX)?
The stock price for Heron Therapeutics (NASDAQ: HRTX) is $1.04 last updated April 22, 2026 at 1:15 PM EDT.
Does Heron Therapeutics (HRTX) pay a dividend?
There are no upcoming dividends for Heron Therapeutics.
When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?
Heron Therapeutics does not have any upcoming earnings scheduled.
Is Heron Therapeutics (HRTX) going to split?
There is no upcoming split for Heron Therapeutics.
What sector and industry does Heron Therapeutics (HRTX) operate in?
Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
